Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:57 pm Purchase | 2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 1,264 6.960% | 1,264 (New Position) | Filing History |
| 2024-02-14 3:24 pm Purchase | 2023-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Armistice Capital, LLC | 53 9.990% | 53 (New Position) | Filing History |
| 2023-02-14 10:15 am Sale | 2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 0 0.000% | -9 (Position Closed) | Filing History |
| 2022-02-10 3:18 pm Sale | 2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Renaissance Technologies LLC | 2 1.400% | -6 (-73.00%) | Filing History |
| 2021-11-26 1:00 pm Sale | 2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 0 0.000% | -28 (Position Closed) | Filing History |
| 2021-11-22 5:28 pm Sale | 2021-11-18 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 28 18.800% | -26 (-47.65%) | Filing History |
| 2021-06-21 09:00 am Unchanged | 2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 39.600% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:13 pm Sale | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Point72 Asset Management, L.P. | 0 0.000% | -9 (Position Closed) | Filing History |
| 2021-02-16 2:51 pm Unchanged | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Armistice Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:56 pm Purchase | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Stonepine Capital Management, LLC | 1 0.400% | 1 (New Position) | Filing History |
| 2021-02-12 09:25 am Sale | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 9 6.960% | -0 (-0.61%) | Filing History |
| 2021-02-10 9:17 pm Purchase | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Renaissance Technologies LLC | 8 5.810% | 8 (New Position) | Filing History |
| 2021-02-09 08:30 am Unchanged | 2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 40.200% | 0 (Unchanged) | Filing History |
| 2020-11-27 2:30 pm Purchase | 2020-11-17 | 13G | Aptevo Therapeutics Inc. APVO | Orin Hirschman | 4 2.950% | 4 (New Position) | Filing History |
| 2020-11-18 5:03 pm Unchanged | 2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 42.500% | 0 (Unchanged) | Filing History |
| 2020-11-16 11:02 am Purchase | 2020-11-05 | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 9 8.970% | 9 (New Position) | Filing History |
| 2020-11-06 4:52 pm Purchase | 2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 54.400% | 54 (New Position) | Filing History |